Article
Transplantation of IPSC-Derived Cardiomyocyte Patches for Ischemic Cardiomyopathy
2022-01-02
Abstract excerpt
<h4>Background</h4> Despite major therapeutic advances, heart failure remains a life-threatening disorder, with 26 million patients worldwide, causing more deaths than cancer as a non-communicable disease. Therefore, novel strategies for the treatment of heart failure continue to be an important clinical need. Based on preclinical studies, allogenic human-induced pluripotent stem cell-derived cardiomyocyte (hiPSC-...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 63d75e0b-15f6-55b1-874a-42d3b37e0fe6
- DOI
- 10.1101/2021.12.27.21268295
